Shawn Leland
Director/Board Member at Fore Biotherapeutics, Inc.
Net worth: 4 M $ as of 31/03/2024
Profile
Shawn M.
Leland was the founder of Elevation Oncology, Inc. (founded in 2019) where he held the title of President, Chief Executive Officer & Director from 2020 to 2023.
He is currently working as a Director at Fore Biotherapeutics, Inc. since 2023.
Previously, Dr. Leland worked as a Senior Director-Corporate Development & Strategy at Argos Therapeutics, Inc. from 2013 to 2017 and as a Vice President-Business Development at Verastem, Inc. from 2017 to 2019.
He obtained his undergraduate degree from Albany College of Pharmacy & Health Sciences.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ELEVATION ONCOLOGY, INC.
1.74% | 31/03/2023 | 846,826 ( 1.74% ) | 4 M $ | 31/03/2024 |
Shawn Leland active positions
| Companies | Position | Start |
|---|---|---|
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Director/Board Member | 01/09/2023 |
Former positions of Shawn Leland
| Companies | Position | End |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Founder | 05/01/2023 |
| VERASTEM, INC. | Corporate Officer/Principal | 01/08/2019 |
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2017 |
Training of Shawn Leland
| Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VERASTEM, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
| Elevation Oncology, Inc. |
- Stock Market
- Insiders
- Shawn Leland
